Newgenivf Group Limited Stock Market Value
| NIVFW Stock | 0.05 0.0002 0.42% |
| Symbol | NewGenIvf |
NewGenIvf Group Company Valuation
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NewGenIvf Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NewGenIvf Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NewGenIvf Group.
| 05/23/2023 |
| 12/13/2024 |
If you would invest 0.00 in NewGenIvf Group on May 23, 2023 and sell it all today you would earn a total of 0.00 from holding NewGenIvf Group Limited or generate 0.0% return on investment in NewGenIvf Group over 570 days. NewGenIvf Group is related to or competes with Regeneron Pharmaceuticals, Catalyst Pharmaceuticals, Mind Medicine, Ardelyx, United Microelectronics, Everspin Technologies, and Amkor Technology. NewGenIvf Group is entity of United States More
NewGenIvf Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NewGenIvf Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NewGenIvf Group Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 23.46 | |||
| Information Ratio | 0.1269 | |||
| Maximum Drawdown | 200.97 | |||
| Value At Risk | (40.44) | |||
| Potential Upside | 54.13 |
NewGenIvf Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NewGenIvf Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NewGenIvf Group's standard deviation. In reality, there are many statistical measures that can use NewGenIvf Group historical prices to predict the future NewGenIvf Group's volatility.| Risk Adjusted Performance | 0.1046 | |||
| Jensen Alpha | 4.5 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.1694 | |||
| Treynor Ratio | (0.98) |
NewGenIvf Group Backtested Returns
NewGenIvf Group is out of control given 3 months investment horizon. NewGenIvf Group has Sharpe Ratio of 0.19, which conveys that the firm had a 0.19% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 6.64% are justified by taking the suggested risk. Use NewGenIvf Group Mean Deviation of 20.95, risk adjusted performance of 0.1046, and Downside Deviation of 23.46 to evaluate company specific risk that cannot be diversified away. NewGenIvf Group holds a performance score of 15 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -4.15, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NewGenIvf Group are expected to decrease by larger amounts. On the other hand, during market turmoil, NewGenIvf Group is expected to outperform it. Use NewGenIvf Group sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to analyze future returns on NewGenIvf Group.
Auto-correlation | -0.34 |
Poor reverse predictability
NewGenIvf Group Limited has poor reverse predictability. Overlapping area represents the amount of predictability between NewGenIvf Group time series from 23rd of May 2023 to 3rd of March 2024 and 3rd of March 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NewGenIvf Group price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current NewGenIvf Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NewGenIvf Group lagged returns against current returns
Autocorrelation, which is NewGenIvf Group stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NewGenIvf Group's stock expected returns. We can calculate the autocorrelation of NewGenIvf Group returns to help us make a trade decision. For example, suppose you find that NewGenIvf Group has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NewGenIvf Group regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NewGenIvf Group stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NewGenIvf Group stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NewGenIvf Group stock over time.
Current vs Lagged Prices |
| Timeline |
NewGenIvf Group Lagged Returns
When evaluating NewGenIvf Group's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NewGenIvf Group stock have on its future price. NewGenIvf Group autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NewGenIvf Group autocorrelation shows the relationship between NewGenIvf Group stock current value and its past values and can show if there is a momentum factor associated with investing in NewGenIvf Group Limited.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NewGenIvf Stock Analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.